Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The scalp extracellular matrix (ECM) is a complex, non-cellular network of proteins and polysaccharides that provides the essential structural scaffold for hair follicles and surrounding dermal tissues. It is primarily composed of various collagen types, elastin, and proteoglycans, which together regulate the mechanical properties of the scalp and facilitate cell-to-matrix signaling (Abhijit et al., 2022). In healthy scalp tissue, the ECM undergoes constant remodeling to support the different phases of the hair growth cycle, particularly during the transition between anagen and catagen. However, pathological changes in ECM composition, such as the accumulation of dense collagen bundles known as perifollicular fibrosis, are closely associated with the progression of androgenetic alopecia and other scarring alopecias (Kligman, 1988; Jaworsky et al., 1992). These fibrotic changes increase scalp stiffness and are thought to physically constrict the hair follicle, contributing to its miniaturization and eventual loss of function. Therapeutic interventions targeting the scalp ECM aim to restore its elasticity and healthy composition by stimulating fibroblast activity, inhibiting matrix metalloproteinases (MMPs), or modulating fibrotic signaling pathways like TGF-beta (Philpott et al., 1996; Shwartz et al., 2020). Drugs such as minoxidil and various collagen-stimulating agents are often employed to modify this environment and promote a more favorable niche for hair regrowth (Murad et al., 1994).
Modulation of the scalp extracellular matrix involves the stimulation of dermal fibroblasts to synthesize high-quality Type I and Type III collagen, the inhibition of matrix metalloproteinases (MMPs) to prevent excessive protein degradation, and the antagonism of pro-fibrotic signaling molecules such as TGF-beta1 to reduce perifollicular fibrosis.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Scalp extracellular matrix (Scalp ECM).